Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans
Authors
Keywords
Somatic mutation, Metastasis, Fusion genes, Cancer treatment, Mutation databases, Carcinogenesis, Evolutionary genetics, Silent mutation
Journal
PLoS One
Volume 12, Issue 10, Pages e0185826
Publisher
Public Library of Science (PLoS)
Online
2017-10-05
DOI
10.1371/journal.pone.0185826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss
- (2016) S. Stacchiotti et al. MOLECULAR CANCER RESEARCH
- NF-κB Mediates the Expression of TBX15 in Cancer Cells
- (2016) Jéssica Arribas et al. PLoS One
- Novel antiapoptotic effect of TBX15: overexpression of TBX15 reduces apoptosis in cancer cells
- (2015) Jéssica Arribas et al. APOPTOSIS
- Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
- (2015) M. Watanabe et al. CLINICAL CANCER RESEARCH
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples
- (2015) Ensel Oh et al. PLoS One
- PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications
- (2013) Sang Yun Ha et al. HUMAN PATHOLOGY
- EXCAVATOR: detecting copy number variants from whole-exome sequencing data
- (2013) Alberto Magi et al. GENOME BIOLOGY
- Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
- (2012) Kang-Yi Su et al. JOURNAL OF CLINICAL ONCOLOGY
- FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution
- (2011) Huanying Ge et al. BIOINFORMATICS
- Evolutionary Modeling of Combination Treatment Strategies To Overcome Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2011) Shannon M. Mumenthaler et al. MOLECULAR PHARMACEUTICS
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
- (2010) Piotr Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
- (2009) Y. Kuang et al. CLINICAL CANCER RESEARCH
- Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays
- (2007) Kayuri U. Patel et al. HUMAN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now